Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 3, 2003, Pages 495-501

  Schindler, Thomas H ^a,b,d   Hornig, Burkhard ^a,c   Buser, Peter T ^b   Olschewski, Manfred ^a   Magosaki, Nobuhisa ^a   Pfisterer, Matthias ^b   Nitzsche, Egbert U ^a,b   Solzbach, Ulrich ^a   Just, Hanjörg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C reactive protein; Coronary disease; Endothelium; Free radicals; Prognosis

Indexed keywords

C REACTIVE PROTEIN; FREE RADICAL; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THALLIUM 201; TRIACYLGLYCEROL;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL REACTIVITY; CEREBROVASCULAR ACCIDENT; COLD PRESSOR TEST; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; EPICARDIUM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; VASOCONSTRICTION; VASODILATATION;

C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 0037340979     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000057571.03012.F4     Document Type: Article

References (36)

1. Goode GK, Miller JP, Heagerty AM. Hyperlipidemia, hypertension and coronary heart disease. Lancet. 1995;345:362-364.
2. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Disease. 1997;4:287-324.
3. Griendling KK, Alexander RW. Oxidative stress and vascular disease. Circulation. 1997;96:3264-3265.
4. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
5. Fuster V, Badimon L, Vadimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med. 1992;326:310-318.
6. Zeiher AM, Drexler H, Wollschläger H, Saurbier, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol. 1989;14:1181-1190.
7. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by cold pressor test. Circulation. 1988;77:43-52.
8. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601-605.
9. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
10. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Ganz P, Selwyn AP. The effect of atherosclerosis of the vasomotor response of coronary arteries to mental stress. N Engl J Med. 1991;325:1551-1556.
11. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR, Tajik AJ. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol. 1995;26:41-49.
12. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1202.
13. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948-959.
14. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafana A, Ferraro A, Chello M, Mastroroberto P, Verdicchio P, Schillaci G. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-201.
15. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-2678.
16. Garvin AA, Cullom SJ, Garcia EV. Myocardial perfusion imaging using single-photon emission computed tomography. Am J Card Imaging. 1994;22:189-198.
17. Wollschläger H, Lee P, Zeiher AM, Solzbach U, Just H. Improvement of quantitative angiography by exact calculation of radiological magnification factor. IEEE Computers Cardiol. 1985;6:483-486.
18. Scanlon PJ, Faxon DP, and AM Audet. ACC/AHA Guidelines for Coronary Angiography. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol. 1999;33:1756-1824.
19. Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96:3390-3395.
20. Zeiher AM, Krause T, Schächinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced ischemia. Circulation. 1995;91:2345-2352.
21. Fichtlscherer S, Rosenberger G, Walter D, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000;102:1000-1006.
22. Hallcox JPJ, Schenke WH, Zalos GRN, Mincermoyer R, Prasad A, Waclawiw MA, Nour KR, Quyymi AA. Prognostic value of coronary endothelial dysfunction. Circulation. 2002;106:653-658.
23. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
24. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408-416.
25. Harrison DG. Cellular and molecular mechanisms of endothelial dysfunction. J Clin Invest. 1997;100:2153-2157.
26. Blake GJ, Ridker PM. C-reactive protein, subclinical atherosclerosis and risk of cardiovascular events. Arterioscler Thromb Vasc Biol. 2002;22:1512-1513.
27. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RM, Cushmann M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
28. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM. C-reactive protein, fibrin D-dimer, and the incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turn over linked in the pathogenesis? Arterioscler Thromb Vasc Biol. 2001;21:603-610.
29. Mancini GBJ, Henry GC, Macaya C, O'Neil BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luescher TF, Klibauer MI, Sprichard AC, Haber HE, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing Endothelial Dysfunction) study. Circulation. 1996;94:258-264.
30. Anderson TJ, Meredith IT, Yeung AC, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
31. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
32. Lüscher TF, Zeiher AM, Meinertz T. Effects of calcium antagonism and HMG-CoA-enzyme reductase inhibition on endothelial dysfunction and atherosclerosis: rationale and outline of the ENCORE trials. J Cardiovasc Pharmacol. 1997;30(suppl 3):S48-S53.
33. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995;92:1094-1100.
34. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, Celermajer DS. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998;32:123-127.
35. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study. J Am Coll Cardiol. 1995;25:807-814.
36. Erbel R, Ge J, Bockisch A, Kearney P, Gorge G, Haude M, Schumann D, Zamarano J, Rupprecht HJ, Meyer J. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J. 1996;17:880-889.